 |
4/5/5390 |
Cryogenic conditions Handling of Sodamide reagent HVD purification |
Polymerization reactions Pharmaceutical applications. |
50-100 Kg |
 |
70788-30-6 |
Grignard reaction Hydrogenation |
Fragrances |
50-100 Kg |
 |
2646-91-5 |
Cryo-reaction |
Pharmaceutical application |
100-200 Kg |
 |
644985-24-0 |
Cryo-reaction |
Pharmaceutical application |
100-200 Kg |
 |
17345-61-8 |
High temperature reactions |
Pharmaceutical application Electronic materials synthesis (OLED & OVP) |
100-200 Kg |
 |
91715-78-5 |
Nitration |
Pharmaceutical application |
100-200 Kg |
 |
151266-23-8 |
Iodination |
Pharmaceutical application |
100-200 Kg |
 |
2380-63-4 |
Deoxychlorination Vilsmeier Formylation |
Pharmaceutical application |
100-200 Kg |
 |
20511-12-0 |
Iodination |
Pharmaceutical application |
200-300 kg |
 |
1072-97-5 |
Bromination |
Pharmaceutical application |
200-300 kg |
 |
69045-79-0 |
Diazotation |
Pharmaceutical application |
100-200 kg |
 |
873107-98-3 |
Trifluoromethylation |
Pharmaceutical application |
25-50 kg |
 |
853-67-8 |
Sulfonation with fuming sulphuric acid |
Electrochemical application |
200-300 kg |
 |
|
High temperature reaction (180-200 °C) |
Electrochemical application |
100-200 kg |
 |
39008-90-7 |
High temperature reaction (180-200 °C) |
Electrochemical application |
100-200 kg |
 |
6370-33-8 |
Acidic conditions at >100 °C |
Dyes preparation |
100-200 kg |
 |
27152-09-6 |
High temperature reactions |
Pharmaceutical application |
25-50 kg |
 |
1250840-53-9 |
Chlorination |
Pharmaceutical application |
25-50 kg |
 |
29334-67-6 |
N-alkylation |
Pharmaceutical application |
50-100 kg |
 |
73259-08-2 |
Oxidation |
Pharmaceutical application |
50-100 kg |
 |
490-91-5 |
Oxidation |
Pharmaceutical application |
50-100 kg |
 |
5013-77-4 |
N-Alkylation |
Pharmaceutical application |
400-500 kg |
 |
18523-22-3 |
Bromination |
Pharmaceutical application |
400-500 kg |
 |
1234366-97-2 |
N-alkylation |
Pharmaceutical application |
400-500 kg |
 |
1870821-29-6 |
Acid catalyzed cyclisation |
Pharmaceutical application |
400-500 kg |
 |
34402-92-1 |
Organic synthesis |
Pharmaceutical application |
400-500 kg |
 |
3979-80-4 |
C-C coupling |
Pharmaceutical application |
100-200 kg |
 |
3974-18-3 |
Chlorination |
Pharmaceutical application |
25-50 kg |
 |
2877662-31-0 |
Chloro to amine |
Pharmaceutical application |
25-50 kg |
 |
1177015-72-3 |
Substituted styrene |
Pharmaceutical application |
100-200 kg |
 |
159465-27-7 |
Nitro reduction |
Pharmaceutical application |
100-200 kg |
 |
1177015-73-4 |
Fmoc protection |
Pharmaceutical application |
100-200 kg |
 |
1177015-74-5 |
Cyclisation |
Pharmaceutical application |
100-200 kg |
 |
1177015-75-6 |
N-deprotection & salt formation |
Pharmaceutical application |
100-200 kg |
 |
1291487-26-7 |
Oxidation |
Pharmaceutical application |
100-200 kg |
 |
2640364-17-4 |
N-alkylation |
Pharmaceutical application |
100-200 kg |
 |
|
Alkylation |
Pharmaceutical application |
100-200 kg |
 |
10169-50-3 |
Bromination |
Pharmaceutical application |
100-200 kg |
 |
91983-31-2 |
Esterification |
Pharmaceutical application |
100-200 kg |
 |
3017242-79-1 |
Nitro reduction |
Pharmaceutical application |
100-200 kg |
 |
13949-99-0 |
Cyclopropane reaction |
Pharmaceutical application |
100-200 kg |
 |
705-35-1 |
Ester hydrolysis |
Pharmaceutical application |
100-200 kg |
 |
187681-87-4 |
Cyclopropane anhydride reaction |
Pharmaceutical application |
100-200 kg |
 |
186376-28-3 |
Azabicyclic carboxylic acid |
Pharmaceutical application |
100-200 kg |
 |
146726-13-8 |
Azabicyclic ethyl ester |
Pharmaceutical application |
100-200 kg |
 |
146655-41-6 |
Azabicyclic keto reduction |
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
|
|
Pharmaceutical application |
100-200 kg |
 |
7175-81-7 |
Chiral resolution |
Pharmaceutical application |
100-200 kg |
 |
7202-43-9 |
Chiral resolution |
Pharmaceutical application |
100-200 kg |
 |
38275-39-7 |
Heterocycle chemistry |
Pharmaceutical application |
100-200 kg |
 |
74840-34-9 |
Ester hydrolysis |
Pharmaceutical application |
100-200 kg |
 |
1224704-99-6 |
N-alkylation |
Pharmaceutical application |
100-200 kg |
 |
2538602-06-9 |
Substituted bicyclic Hydrazine |
Pharmaceutical application |
100-200 kg |
 |
1826900-79-1 |
Substituted bicyclic amine |
Pharmaceutical application |
100-200 kg |
 |
1826900-85-9 |
Substituted bicyclic -boc protected amine |
Pharmaceutical application |
100-200 kg |
 |
69471-05-2 |
|
Pharmaceutical application |
100-200 kg |
 |
80749-72-0 |
|
Pharmaceutical application |
100-200 kg |
 |
13239-13-9 |
|
Pharmaceutical application |
100-200 kg |
 |
52643-52-4 |
|
Pharmaceutical application |
100-200 kg |
 |
497967-47-2 |
|
Pharmaceutical application |
100-200 kg |
 |
55687-11-1 |
|
Pharmaceutical application |
100-200 kg |
 |
1093879-99-2 |
Esterification |
Pharmaceutical application |
100-200 kg |
 |
518357-43-2 |
Nitro to amine reduction |
Pharmaceutical application |
100-200 kg |
 |
863868-34-2 |
Boronic ester |
Pharmaceutical application |
100-200 kg |
 |
773128-56-6 |
Esterification |
Pharmaceutical application |
100-200 kg |
 |
1126636-59-6 |
Oxazole formation |
Pharmaceutical application |
100-200 kg |
 |
1017513-51-7 |
Ester hydrolysis |
Pharmaceutical application |
100-200 kg |